Skip to main content
Log in

Chronisch interstitielle Lungenerkrankungen

Was ist bei Beatmung und Hämodynamik wichtig?

Chronic interstitial pulmonary disease

What is important for ventilation and hemodynamics?

  • Leitthema
  • Published:
Der Pneumologe Aims and scope

Zusammenfassung

Die akute Exazerbation einer interstitiellen Lungenerkrankung ist gekennzeichnet durch eine kritische Verschlechterung des Gasaustauschs und der Ventilation. Neben der Exazerbation der Grunderkrankung sind in erster Linie akute, schwere Infektionen, akute Lungenembolie oder das Auftreten eines Pneumothorax Ursachen für die klinische Verschlechterung. Das klinische Bild wird dominiert durch eine zunehmende respiratorische Insuffizienz, die eine mechanische Atmungsunterstützung (nichtinvasiv oder invasiv) erfordert. Die Mortalität von beatmungspflichtigen Patienten mit akuter Verschlechterung einer interstitiellen Lungenerkrankung ist sehr hoch und liegt zwischen 80 und 100 %, so dass die Indikation für eine mechanische Beatmungsunterstützung kritisch gesehen werden muss. Die Einstellung und Durchführung der mechanischen Beatmung richtet sich sehr nach der individuellen pathophysiologischen Situation und stellt eine große Herausforderung an den Intensivmediziner dar.

Abstract

Acute exacerbation of interstitial pulmonary disease is characterized by a critical deterioration of gas exchange and respiration. In addition to exacerbation of the underlying disease, the causes of the clinical deterioration are primarily acute severe infections, acute pulmonary embolism and the occurrence of pneumothorax. The clinical picture is characterized by increasing respiratory insufficiency which necessitates mechanical respiratory support (non-invasive or invasive). The mortality of ventilated patients with acute deterioration of interstitial pulmonary disease is very high and ranges between 80 and 100 % so that the indications for mechanical respiratory support must be viewed critically. The conditions and performance of mechanical ventilation depend very much on the individual pathophysiological situation and represent a great challenge for intensive care physicians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Raghu G, Collard HR, Egan JJ et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824

    Article  PubMed  Google Scholar 

  2. Collard HR, Moore BB, Flaherty KR et al (2007) Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176:636–643

    Article  PubMed  Google Scholar 

  3. Song JW, Hong SB, Lim CM et al (2011) Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J 37:356–363

    Article  PubMed  CAS  Google Scholar 

  4. Kim DS, Park JH, Park BK et al (2006) Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 27:143–150

    Article  PubMed  CAS  Google Scholar 

  5. Ricard JD (2012) High flow nasal oxygen in acute respiratory failure. Minerva Anestesiol 78:836–841

    PubMed  Google Scholar 

  6. Corley A, Caruana LR, Barnett AG et al (2011) Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. Br J Anaesth 107:998–1004

    Article  PubMed  CAS  Google Scholar 

  7. Parke RL, McGuinness SP, Dixon R et al (2012) Protocol for a randomised controlled trial of nasal high flow oxygen therapy compared to standard care in patients following cardiac surgery: the HOT-AS study. Int J Nurs Stud 49:338–344

    Article  PubMed  Google Scholar 

  8. Braunlich J, Beyer D, Mai D et al (2013) Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patients. Respiration 85:319–325

    Article  PubMed  Google Scholar 

  9. Mallick S (2008) Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit. Respir Med 102:1355–1359

    Article  PubMed  Google Scholar 

  10. Watanabe A, Kawaharada N, Higami T (2011) Postoperative acute exacerbation of IPF after lung resection for primary lung cancer. Pulm Med 2011:960316

    PubMed  Google Scholar 

  11. Mollica C, Paone G, Conti V et al (2010) Mechanical ventilation in patients with end-stage idiopathic pulmonary fibrosis. Respiration 79:209–215

    Article  PubMed  Google Scholar 

  12. Papiris SA, Manali ED, Kolilekas L et al (2010) Clinical review: idiopathic pulmonary fibrosis acute exacerbations – unravelling Ariadne’s thread. Crit Care 14:246

    Article  PubMed  Google Scholar 

  13. Kondoh Y, Taniguchi H, Kawabata Y et al (1993) Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest 103:1808–1812

    Article  PubMed  CAS  Google Scholar 

  14. (o A) (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The acute respiratory distress syndrome network. N Engl J Med 342:1301–1308

  15. Fernandez-Perez ER, Yilmaz M, Jenad H et al (2008) Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease. Chest 133:1113–1119

    Article  PubMed  Google Scholar 

  16. Kolb M (2013) Persönliche Kommunikation

  17. Shorr AF, Wainright JL, Cors CS et al (2007) Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 30:715–721

    Article  PubMed  CAS  Google Scholar 

  18. Muller T, Lubnow M, Philipp A et al (2009) Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy. Eur Respir J 33:551–558

    Article  PubMed  CAS  Google Scholar 

  19. Bein T, Weber F, Philipp A et al (2006) A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med 34:1372–1377

    Article  PubMed  Google Scholar 

  20. Fischer S, Simon AR, Welte T et al (2006) Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung. J Thorac Cardiovasc Surg 131:719–723

    Article  PubMed  Google Scholar 

  21. Fuehner T, Kuehn C, Hadem J et al (2012) Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med 185:763–768

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Pfeifer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pfeifer, M. Chronisch interstitielle Lungenerkrankungen. Pneumologe 10, 253–257 (2013). https://doi.org/10.1007/s10405-012-0619-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10405-012-0619-6

Schlüsselwörter

Keywords

Navigation